Artificial intelligence applied to oncology: Quebec grants its first $3 million to Imagia

The Government of Québec awards, through the BioMed Propulsion program, a $ 3 million loan to Imagia to support an artificial intelligence project applied to personalized healthcare.

« We are proud to be the first AI Healthcare company to receive this funding. It sends a clear message about the importance of supporting both research and local industry. This collaborative ecosystem between industry and research will maintain and attract the talent specialized in AI in Québec.»

Alexandre Le Bouthillier,
Ph.D., co-founder of Imagia

Related posts

Digital Technology Supercluster Announces Investment to Increase the Effectiveness of Precision Oncology

Digital Technology Supercluster Announces Investment to Increase the Effectiveness of Precision Oncology

Harnessing artificial intelligence to take the guesswork out of diagnosing cancer recurrence for millions of cancer survivors

Read more
How to Bring Biomarker Testing In-House for Cancer Targeted Treatment Selection

How to Bring Biomarker Testing In-House for Cancer Targeted Treatment Selection

Personalized cancer treatment via targeted therapies is two-to-three times more effective than standard chemotherapy for patients with advan

...
Read more
Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger

...
Read more